Catheter ablation of atrial fibrillation: current status, techniques, outcomes and challenges
- PMID: 30406938
- DOI: 10.5603/KP.a2018.0216
Catheter ablation of atrial fibrillation: current status, techniques, outcomes and challenges
Abstract
Atrial fibrillation (AF) is the most common human arrhythmia. Interventional treatment with catheter ablation is an established technique that is increasingly applied and has become one of the main treatment modalities in patients with AF. Ablation results in significant improvement of symptoms and the quality of life. There is as yet no clear evidence of any impact of the procedure on hard clinical endpoints, except in patients with heart failure, who seem to benefit significantly from ablation. The cornerstone of the procedure is the achievement of pulmonary vein isolation. Radiofrequency energy is the main applied energy source, but cryoballoon ablation has emerged as a safe and effective alternative to radiofrequency ablation. Additional ablation strategies and novel technical features have been proposed but without unequivocal proof of clinical benefit. The most promising of these seems to be substrate mapping of the left atrium with substrate modification in areas with low voltage as an adjunct to pulmonary vein isolation. Complication rates remain considerable despite accumulated experience and can be partly reduced by application of preventive measures.
Keywords: atrial fibrillation; catheter ablation; complications.
Similar articles
-
[Interventional therapy of atrial fibrillation: possibilities and limitations].Dtsch Med Wochenschr. 2010 Mar;135 Suppl 2:S48-54. doi: 10.1055/s-0030-1249209. Epub 2010 Mar 10. Dtsch Med Wochenschr. 2010. PMID: 20221979 Review. German.
-
Ablation of atrial fibrillation with cryoballoon or duty-cycled radiofrequency pulmonary vein ablation catheter: a randomized controlled study comparing the clinical outcome and safety; the AF-COR study.Europace. 2013 Nov;15(11):1567-73. doi: 10.1093/europace/eut104. Epub 2013 May 22. Europace. 2013. PMID: 23703361 Clinical Trial.
-
Arrhythmia-free survival and pulmonary vein reconnection patterns after second-generation cryoballoon and contact-force radiofrequency pulmonary vein isolation.Clin Res Cardiol. 2018 Jun;107(6):498-506. doi: 10.1007/s00392-018-1211-9. Epub 2018 Feb 6. Clin Res Cardiol. 2018. PMID: 29411114 Clinical Trial.
-
[Cryoballoon ablation for pulmonary vein isolation to treat atrial fibrillation: first experience in Russian Federation].Kardiologiia. 2012;52(4):38-48. Kardiologiia. 2012. PMID: 22839515 Russian.
-
Canadian Cardiovascular Society atrial fibrillation guidelines 2010: catheter ablation for atrial fibrillation/atrial flutter.Can J Cardiol. 2011 Jan-Feb;27(1):60-6. doi: 10.1016/j.cjca.2010.11.011. Can J Cardiol. 2011. PMID: 21329863
Cited by
-
Exosomes in atrial fibrillation: therapeutic potential and role as clinical biomarkers.Heart Fail Rev. 2022 Jul;27(4):1211-1221. doi: 10.1007/s10741-021-10142-5. Epub 2021 Jul 12. Heart Fail Rev. 2022. PMID: 34251579 Review.
-
Cryoballoon versus radiofrequency ablation for persistent atrial fibrillation: an updated systematic review and meta‑analysis.Eur J Med Res. 2025 Jul 18;30(1):639. doi: 10.1186/s40001-025-02911-x. Eur J Med Res. 2025. PMID: 40676688 Free PMC article. Review.
-
Rhythm Control in AF: Have We Reached the Last Frontier?Eur Cardiol. 2019 Jul 11;14(2):77-81. doi: 10.15420/ecr.2019.8.1. eCollection 2019 Jul. Eur Cardiol. 2019. PMID: 31360227 Free PMC article. Review.
-
[2020 ESC guidelines on atrial fibrillation : Summary of the most relevant recommendations and innovations].Herz. 2021 Feb;46(1):28-37. doi: 10.1007/s00059-020-05005-y. Herz. 2021. PMID: 33289046 Review. German.
-
World Heart Federation Roadmap on Atrial Fibrillation - A 2020 Update.Glob Heart. 2021 May 27;16(1):41. doi: 10.5334/gh.1023. Glob Heart. 2021. PMID: 34211827 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical